A Study of LY3561774 in Participants With Mixed Dyslipidemia

Clinical trial NCT05256654 · COMPLETED

Trial details

NCT number: NCT05256654
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases Hyperlipoproteinemia

Start date: 2022-07-20
Primary completion: 2024-03-04
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.